3.81MMarket Cap-49P/E (TTM)
0.380High0.330Low7.33MVolume0.360Open0.340Pre Close2.58MTurnover71.28%Turnover RatioLossP/E (Static)10.30MShares23.00052wk High0.31P/B3.80MFloat Cap0.31352wk Low--Dividend TTM10.29MShs Float719999.520Historical High--Div YieldTTM14.59%Amplitude0.313Historical Low0.351Avg Price1Lot Size
Applied DNA Sciences Stock Forum
A public offering is expected to generate approximately $12 million in gross proceeds. Lastly, the company received approval from the New York State Department of Health for its pharmacogenomic testing service, TR8, and plans to implement a reverse stock split to comply with Nasdaq's listing rules.
No comment yet